Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE ATRS and ROM tests' results showed good functional recovery without functional limitations or subjective reports pain. 30837207 2020
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE In the short-term after surgery, this combined method reduces the pain VAS scores and improves the ROM; however, there are no long-term effects on VAS and ROM. 31348286 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE For each leg, study personnel not involved in patient care measured the patients' limb circumference (thigh, knee, and tibia), ROM, and VAS pain scores 24 hours after surgery, 48 hours after surgery, and on POD 28. 30794237 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 GeneticVariation phenotype BEFREE We reviewed patients who had undergone open arthrolysis with hinged external fixator for severe posttraumatic elbow stiffness (ROM ≤ 60°) with a minimum of 5 years followup to (1) analyze ROM gains; (2) assess functional improvement with the Mayo Elbow Performance Index (MEPI) and DASH, quality of life with the SF-36, pain with VAS, and ulnar nerve function with the Amadio rating scale and Dellon classification; and (3) identify complications and risk factors that might hinder mid-term elbow motion recovery after this procedure. 31107330 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE For our primary analysis on pain and ROM, a total of eight studies (221 patients in the tourniquet group, 219 patients in the no-tourniquet group) were meta-analyzed. 30461513 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE The effect sizes for corticosteroids were 0.2-0.5 and 0.1 for ROM and pain. 30268804 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE In addition, we found that patients with difficulty in staying asleep and non-restorative sleep has increased pain scores and LOS in hospital with decreased active ROM in comparison to difficulty in falling asleep and too early awakening. 30146382 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE The diagnosis of cam, pincer, or mixed-type FAI was determined by each treating surgeon at each institution using the minimum basic criteria of pain in the affected hip for a period of > 3 months, hip ROM, and radiographic findings. 30998630 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 GeneticVariation phenotype BEFREE Patients with 2-year minimum follow-up had significant improvements in ROM, Knee Society Clinical, Functional and Pain scores (p < 0.005).Nine (0.8%) patients required revision. 31104079 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE Before and after experimental conditions (Pre-stimulation, Post-stimulation), the maximum Hip ROM and pain perception was measured. 31158433 2019
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE For patients with pain and/or ROM deficits, will CE decrease pain and increase ROM? 27992295 2018
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 GeneticVariation phenotype BEFREE In addition, patients treated with S-ROM hip stems scored worse than those with Summit hip stems in 4 of the 5 patient-reported outcome measures: Harris Hip Score, Visual Analog Scale pain, University of California at Los Angeles activity, and EQ-5D index. 28947371 2018
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE Participants were required to achieve ≥ 80% quadriceps muscle strength symmetry, minimal knee effusion, full ROM, no reports of pain, and completion of a running progression (all between 3 and 9 months postoperatively) before enrollment. 28224442 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE Pain (using visual analogue scale), ROM (using digital goniometer), muscle strength (using dynamometer and pinch gauge), functional status (using Constant-Murley scale and Disabilities of the Arm, Shoulder and Hand scale) were evaluated before and after intervention. 27339709 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE The preoperative KSS, ROM, and pain visual analog scale (VAS); the objective parameters including drainage volume and swelling evaluated by the circumference of the 10 cm above the patella; and the preoperative and postoperative (1st, 3rd, and 7th days) subjective parameters including pain, satisfaction VAS, and patient satisfaction of the first and second surgeries for each knee were analyzed. 28747231 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE High-intensity strength training during the preoperative period reduces pain and improves lower limb muscle strength, ROM and functional task performance before surgery, resulting in a reduced length of stay at the hospital and a faster physical and functional recovery after TKA. 26768606 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE We evaluated pain and ROM, and Kaplan-Meier curves were used to estimate survivorship. 28849539 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE Development of surgical resection guidelines therefore could reduce the number of patients with persistent pain and reduced ROM after femoroplasty. 28342138 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE QUESTION/PURPOSE: (1) To report ROM and pain scores after wrist reconstruction with cementless fourth-generation TWA at a mean followup of 9 years (range, 4.8-14.7 years). 28721601 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 GeneticVariation phenotype BEFREE Compared with placebo-sham acupuncture, scraping combined with warming acupuncture and moxibustion was found to be more effective for decreasing pain intensity (standardized mean difference (SMD) = -3.6, 95% confidence interval (CI) ranging from -5.2 to -2.1); miniscalpel-needle was more effective for increasing the PPT (SMD = 2.2, 95% CI ranging from 1.2 to 3.1); trigger points injection with bupivacaine was associated with the highest risk of adverse event (odds ratio = 557.2, 95% CI ranging from 3.6 to 86867.3); and only EA showed a significant difference in the ROM (SMD = -4.4, 95% CI ranging from -7.5 to -1.3). 28934793 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE Pain and function were measured using the Merle d'Aubigné and Postel score, limp, ROM, and the presence of a positive anterior impingement test or Drehmann sign. 28194709 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 GeneticVariation phenotype BEFREE Improvements in ROM (37/38) and contractures-related pain (12/12) were satisfactory. 27993587 2017
Entrez Id: 6094
Gene Symbol: ROM1
ROM1
0.100 Biomarker phenotype BEFREE We asked whether (1) the complication rates were low; (2) the components were stable; (3) the patients achieved pain relief; and (4) the patients had satisfactory midterm function, ROM, and quality of life. 20665138 2011